Price Increase Summary - The company has announced a price increase for several chemical products across different regions, including the USA, Canada, Mexico, South America, and EMEA [1] Product Pricing Details - Acetic Acid prices will increase by $50 in the USA and Canada, $50 in Mexico and South America, and €50 in EMEA [1] - Vinyl Acetate Monomer prices will rise by $100 in the USA and Canada, $100 in Mexico and South America, and €100 in EMEA [1] - Acetic Anhydride prices will see an increase of $60 in all regions: USA, Canada, Mexico, South America, and EMEA [1] - Esters will also have a price increase of $50 across the USA, Canada, Mexico, South America, and €50 in EMEA [1]

Company Overview - Calumet generated revenue of $4.05 billion and reported a net income of -$37.20 million for the trailing twelve months [5] - The company's stock price as of Monday was $20.07, reflecting a one-year price change of -2% [5] Recent Developments - Alta Fundamental Advisers fully exited its position in Calumet by selling 459,937 shares, resulting in a net position change of $7.25 million [2][3][7] - This sale reduced Alta's stake in Calumet from approximately 3.71% of its reportable assets under management [3] Market Performance - As of the latest data, Calumet's shares were priced at $20.07, which is underperforming compared to the S&P 500, which has increased by 16% over the past year [4] Business Operations - Calumet specializes in manufacturing and marketing a range of specialty branded products, including solvents, lubricating oils, and renewable fuels [9][10] - The company serves various sectors, including industrial manufacturers, transportation, energy, and retail consumers [10] Financial Insights - Calumet recently reported a significant quarter with $313 million in net income and $92.5 million in adjusted EBITDA, driven by record margins in its Specialty Products segment [11] - Despite this positive performance, the company faces challenges such as heavy leverage, volatile cash flows, and reliance on tax credits [11][12] Strategic Positioning - Alta's exit indicates a reassessment of risk-reward dynamics, as the fund's remaining top holdings focus on sectors with clearer near-term cash visibility [12] - Calumet's stock requires sustained execution to improve its valuation, with expectations of continued volatility until renewable margins stabilize [13]